课题基金 / 基金详情

Identification and characterization of molecular targets for novel small molecule inhibitors of lung adenocarcinoma

Identification and characterization of molecular targets for novel small molecule inhibitors of lung adenocarcinoma
肺腺癌新型小分子抑制剂分子靶标的鉴定和表征
批准号：
193860
负责人：
Lockwood William W
金额：
$10.93万
依托单位：
Memorial Sloan Kettering Cancer Center (New York)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-10-01 至 2012-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=193860&lang=en
关键词：
Affinity Chromatography Biochemistry Cell Biology Drug Development Lung Cancer Oncogenes Quantitative Proteomics Small Molecule Inhibitor Target Identification Tumor Biology

项目摘要

项目成果

Lockwood William W的其他基金

相似基金

相关文献

中文摘要
翻译
肺癌是一种毁灭性的疾病，缺乏有效的化疗策略。 最近，我们的实验室筛选了一组189，290种不同的化合物，以寻找治疗肺肿瘤的新药。 分析显示，
英文摘要
Lung cancer is a devastating disease suffering from the lack of effective chemotherapeutic strategies. Recently, our laboratory has screened a panel of 189,290 diverse chemical compounds in search of new agents to treat lung tumours. This analysis revea
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SNF2 Histone Linker PHD RING Helicase as a novel tumor suppressor gene and risk factor in lung adenocarcinoma development
Understanding the effects of ERK hyperactivation in cancer: implications for therapy
The effects of smoking marijuana on lung cancer development: implications for screening and early detection.
  • 批准号：
    410491
  • 项目类别：
    Operating Grants
  • 资助金额：
    $50.16万
  • 财政年份：
    2019
  • 负责人：
    Lockwood William W
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
Developing agonistic therapeutic strategies for lung cancer based on synthetic lethal oncogene interactions
  • 批准号：
    345188
  • 项目类别：
    Operating Grants
  • 资助金额：
    $55.69万
  • 财政年份：
    2016
  • 负责人：
    Lockwood William W
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
海外基金